NCT02441062 2020-12-21Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine TumorsUniversity of IowaPhase 2 Completed122 enrolled 6 charts
NCT00947167 2017-03-03A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine TumorsStanford UniversityPhase 2 Terminated4 enrolled 5 charts